Dynamic changes of quality of life in muscle-invasive bladder cancer survivors
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2490
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Dynamic changes of quality of life in muscle-invasive bladder cancer survivors ; volume:22 ; number:1 ; day:20 ; month:8 ; year:2022 ; pages:1-9 ; date:12.2022
BMC urology ; 22, Heft 1 (20.8.2022), 1-9, 12.2022
- Urheber
-
Tsai, Yuh-Shyan
Wu, Tzu-Yi
Ou, Chien-Hui
Cheng, Hong-Lin
Tzai, Tzong-Shin
Yang, Wen-Horng
Wang, Jung-Der
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12894-022-01084-7
- URN
-
urn:nbn:de:101:1-2022110921033270494694
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tsai, Yuh-Shyan
- Wu, Tzu-Yi
- Ou, Chien-Hui
- Cheng, Hong-Lin
- Tzai, Tzong-Shin
- Yang, Wen-Horng
- Wang, Jung-Der
- SpringerLink (Online service)
Ähnliche Objekte (12)
Bladder Sparing Approaches for Muscle-Invasive Bladder Cancers
Proteomics research on muscle-invasive bladder transitional cell carcinoma
The natural history of secondary muscle-invasive bladder cancer
Stromal proteome expression profile and muscle-invasive bladder cancer research
Epigenetic profiling demarcates molecular subtypes of muscle-invasive bladder cancer
Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer
Alternative splicing patterns reveal prognostic indicator in muscle-invasive bladder cancer
Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancer
The prognostic value of routine preoperative blood parameters in muscle-invasive bladder cancer
Overexpression of KMT9α is associated with aggressive basal-like muscle-invasive bladder cancer
Low adherence to recommended use of neoadjuvant chemotherapy for muscle-invasive bladder cancer
Treatment trends for muscle-invasive bladder cancer in Germany from 2006 to 2019
Bladder Sparing Approaches for Muscle-Invasive Bladder Cancers
Proteomics research on muscle-invasive bladder transitional cell carcinoma
The natural history of secondary muscle-invasive bladder cancer
Stromal proteome expression profile and muscle-invasive bladder cancer research
Epigenetic profiling demarcates molecular subtypes of muscle-invasive bladder cancer
Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer
Alternative splicing patterns reveal prognostic indicator in muscle-invasive bladder cancer
Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancer
The prognostic value of routine preoperative blood parameters in muscle-invasive bladder cancer
Overexpression of KMT9α is associated with aggressive basal-like muscle-invasive bladder cancer
Low adherence to recommended use of neoadjuvant chemotherapy for muscle-invasive bladder cancer
Treatment trends for muscle-invasive bladder cancer in Germany from 2006 to 2019
Bladder Sparing Approaches for Muscle-Invasive Bladder Cancers
Proteomics research on muscle-invasive bladder transitional cell carcinoma
The natural history of secondary muscle-invasive bladder cancer
Stromal proteome expression profile and muscle-invasive bladder cancer research
Epigenetic profiling demarcates molecular subtypes of muscle-invasive bladder cancer
Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer
Alternative splicing patterns reveal prognostic indicator in muscle-invasive bladder cancer
Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancer
The prognostic value of routine preoperative blood parameters in muscle-invasive bladder cancer
Overexpression of KMT9α is associated with aggressive basal-like muscle-invasive bladder cancer
Low adherence to recommended use of neoadjuvant chemotherapy for muscle-invasive bladder cancer